Bio-Gate AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bio-Gate AG with three other
drug stores in Europe:
sales of 209.88 million Norwegian Kroner [US$25.19 million]
EQL Pharma AB
(72.03 million Swedish Kronor [US$8.67 million]
Organicell Regenerative Medicine Inc
based in UNITED KINGDOM
(£2.38 million [US$3.36 million]
Bio-Gate AG reported sales of 5.13 million Euro (US$6.22 million)
December of 2020.
increase of 47.2%
versus 2019, when the company's sales were 3.49 million Euro.
Sales of Veterinary Products saw an increase
that was more than double the company's growth rate: sales were up
291.9% in 2020, from
235,000.00 Euro to 921,000.00 Euro.
Bio-Gate AG also saw significant increases in sales in
Trade Show Services (up 85.6% to 579,000.00 Euro)
Not all segments of Bio-Gate AG experienced an increase in sales in 2020:
sales of Other Revenue fell 94.1% to 1,000.00 Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).